. Author manuscript; available in PMC: 2015 Jul 1.

Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2014 Jul;23(7):1254–1263. doi: 10.1158/1055-9965.EPI-13-1284

Table 4.

Pancreatic cancer odds ratios according to end of continuing aspirin use

	Any aspirin
End of aspirin use (years in past)	No. of controls /cases	OR^a (95% CI)
Use continued during interview year	267/98	1
Never used	345/218	2.23 (1.62–3.06)
>1, ≤2	17/21	3.24 (1.58–6.65)
>2, ≤7	17/10	1.72 (0.75–3.98)
>7	18/6	0.92 (0.34–2.50)

Adjusted as in Table 2.